Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heart Valve Device Approvals: FDA Issues New Draft Guidance

This article was originally published in The Gray Sheet

Executive Summary

A single-arm clinical study with literature-based controls is typically sufficient for a PMA supporting a new open-surgery heart valve replacement device, FDA says in a draft guidance issued Jan. 20
Advertisement

Related Content

Task Force Collaborating With FDA Issues Pediatric Heart Valve Recommendations
Vying Valves: Edwards’ Sapien Progresses, But CoreValve Remains A Threat
Vying Valves: Edwards’ Sapien Progresses, But CoreValve Remains A Threat

Topics

Advertisement
UsernamePublicRestriction

Register

MT028409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel